Consequences of Locus Coeruleus Activation in a Rat Model of Alzheimer's Disease
Consequences of Locus Coeruleus Activation in a Rat Model of Alzheimer's Disease
批准号:
8711845
负责人:
DAVID WEINSHENKER
金额:
$174.71万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-01 至 2019-05-31
关键词:
AcuteAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAmyloid beta-Protein PrecursorAmyloidosisAnimalsApoptoticAttenuatedBehaviorBrainBrain StemBrain-Derived Neurotrophic FactorCell CountCell NucleusCerebrumCessation of lifeChronicCognitionCognitiveCognitive deficitsDataDementiaDiseaseElderlyFacultyFrequenciesFunctional disorderGoalsHealthcare SystemsHumanImpaired cognitionInjection of therapeutic agentInterventionLasersLeadLearningLentivirus VectorLesionLifeLightMemoryMemory impairmentMusNerve DegenerationNeuroanatomyNeurodegenerative DisordersNeurofibrillary TanglesNeuromodulatorNeuronsNeuropeptidesNorepinephrineOutcomePaperPathologyPatientsPeptidesPharmaceutical PreparationsPhysiologic pulsePlayProcessPropertyProsencephalonPsyche structureRattusRelative (related person)RelianceResearchSenile PlaquesSeriesSignal TransductionSocietiesSourceStagingTask PerformancesTauopathiesTherapeuticTissuesTransgenic MiceTransgenic OrganismsWorkagedbasecognitive functiondesignimprovedinfancylocus ceruleus structureloved onesmouse modelneurochemistryneuroinflammationneuron lossneuropathologyneurotransmitter releasenoradrenergicoptogeneticspreventpromoterpublic health relevanceresearch studytau Proteinstau aggregationtransmission processtreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Alzheimer's disease (AD), a neurodegenerative disease that is the most common cause of dementia in the elderly and poses immense burdens on society, is characterized neuropathologically by ¿-amyloid plaques and tau neurofibrillary tangles. A recent series of papers has revealed that AD-like neuropathology can first be detected in the locus coeruleus (LC), a brainstem noradrenergic nucleus implicated in learning and memory that degenerates early in AD. Furthermore, LC lesions exacerbate, while pro-noradrenergic treatments ameliorate, AD-like neuropathology and cognitive deficits in transgenic mouse models of the disease. However, these studies have been limited by reliance on mouse AD models that do not recapitulate critical aspects of the disease such as bona fide tau tangles and neuronal loss. In addition, current noradrenergic manipulations cannot distinguish between the two distinct modes of LC firing, tonic and phasic, which have very different effects on cognition and neurotransmitter release. To overcome these limitations, we will use optogenetics to drive tonic or phasic LC activity in the TgF344-AD transgenic rat that manifests all critical neuropathological and cognitive hallmarks of AD. Completion of these studies will identify the most beneficial firing modes and neuromodulators responsible for the pro-cognitive and neuroprotective properties of the LC, thus laying the groundwork for the design of LC-based therapies for the treatment of AD.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.neulet.2017.02.060
发表时间:
2017-03-22
期刊:
Neuroscience letters
影响因子:
2.5
作者:
[Vadodaria KC, Yanpallewar SU, Vadhvani M, Toshniwal D, Liles LC, Rommelfanger KS, Weinshenker D, Vaidya VA]
通讯作者:
Vaidya VA
Contribution of neuromelanin to selective vulnerability of locus coeruleus neurons in Alzheimer's disease
-
批准号:10525513
-
项目类别:
-
资助金额:$153.16万
-
财政年份:2022
-
负责人:DAVID WEINSHENKER
-
依托单位:
Contribution of locus coeruleus-derived galanin to opioid reward and reinforcement
-
批准号:9981143
-
项目类别:
-
资助金额:$47.19万
-
财政年份:2020
-
负责人:DAVID WEINSHENKER
-
依托单位:
Contribution of locus coeruleus-derived galanin to opioid reward and reinforcement
-
批准号:10456900
-
项目类别:
-
资助金额:$46.38万
-
财政年份:2020
-
负责人:DAVID WEINSHENKER
-
依托单位:
Contribution of locus coeruleus-derived galanin to opioid reward and reinforcement
-
批准号:10669138
-
项目类别:
-
资助金额:$46.38万
-
财政年份:2020
-
负责人:DAVID WEINSHENKER
-
依托单位:
Emory Alzheimer's Disease Research Center
-
批准号:10408030
-
项目类别:
-
资助金额:$15.69万
-
财政年份:2020
-
负责人:DAVID WEINSHENKER
-
依托单位:
Emory Alzheimer's Disease Research Center
-
批准号:10673961
-
项目类别:
-
资助金额:$15.69万
-
财政年份:2020
-
负责人:DAVID WEINSHENKER
-
依托单位:
Emory Alzheimer's Disease Research Center
-
批准号:10212237
-
项目类别:
-
资助金额:$15.69万
-
财政年份:2020
-
负责人:DAVID WEINSHENKER
-
依托单位:
Contribution of locus coeruleus-derived galanin to opioid reward and reinforcement
-
批准号:10268173
-
项目类别:
-
资助金额:$46.37万
-
财政年份:2020
-
负责人:DAVID WEINSHENKER
-
依托单位:
2017 Catecholamines Gordon Research Conference & Gordon Research Seminar
-
批准号:9321523
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2017
-
负责人:DAVID WEINSHENKER
-
依托单位:
Neurobiology of Reward Choice
-
批准号:9304986
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2016
-
负责人:DAVID WEINSHENKER
-
依托单位:
Neurobiology of Reward Choice
-
批准号:9181667
-
项目类别:
-
资助金额:$21.89万
-
财政年份:2016
-
负责人:DAVID WEINSHENKER
-
依托单位:
Glial huntingtin and neurodegeneration
-
批准号:9751408
-
项目类别:
-
资助金额:$34.13万
-
财政年份:2015
-
负责人:DAVID WEINSHENKER
-
依托单位:
Reinstatement of cocaine seeking by social defeat
-
批准号:8582985
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2013
-
负责人:DAVID WEINSHENKER
-
依托单位:
Reinstatement of cocaine seeking by social defeat
-
批准号:8662737
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2013
-
负责人:DAVID WEINSHENKER
-
依托单位:
ENNCF - Rodent Behavior Core
-
批准号:9292387
-
项目类别:
-
资助金额:$9.45万
-
财政年份:2008
-
负责人:DAVID WEINSHENKER
-
依托单位:
ENNCF - Rodent Behavior Core
-
批准号:8991162
-
项目类别:
-
资助金额:$9.45万
-
财政年份:2008
-
负责人:DAVID WEINSHENKER
-
依托单位:
ENNCF - Rodent Behavior Core
-
批准号:9506858
-
项目类别:
-
资助金额:$9.45万
-
财政年份:2008
-
负责人:DAVID WEINSHENKER
-
依托单位:
ENNCF - Rodent Behavior Core
-
批准号:9116318
-
项目类别:
-
资助金额:$9.45万
-
财政年份:2008
-
负责人:DAVID WEINSHENKER
-
依托单位:
Mechanism of Disulfiram-Induced Cocaine Abstinence
-
批准号:7413409
-
项目类别:
-
资助金额:$31.89万
-
财政年份:2006
-
负责人:DAVID WEINSHENKER
-
依托单位:
Mechanism of Disulfiram-Induced Cocaine Abstinence
-
批准号:7033268
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2006
-
负责人:DAVID WEINSHENKER
-
依托单位: